COMMUNIQUÉS West-GlobeNewswire

Phoenix Life Sciences International Announces Dr. Santus Wari as Company's National Head of Healthcare in the Republic of Vanuatu
28/03/2019
DENVER, CO, March 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life” or the “Company”), an adaptive healthcare solutions company, today announced that [...]
Tauriga Sciences Inc. to Present at the ThinkEquity Conference on May 2, 2019 at the Mandarin Oriental Hotel in Manhattan
28/03/2019
New York, NY, March 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, [...]
Fluidigm Showcases New Product Innovations and Research Presentations at the 2019 American Association for Cancer Research (AACR) Meeting
28/03/2019
A comprehensive suite of multi-omic cancer research solutions for deep profiling of the tumor microenvironment and immune response SOUTH SAN FRANCISCO, Calif., March 28, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation ( [...]
Teladoc Health Launches Telemedicine Service in Canada, Expanding Portfolio of Available Healthcare Solutions
28/03/2019
Canadians to benefit from access to anytime, anywhere high-quality physician care TORONTO, March 28, 2019 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, announces today the launch of [...]
Teladoc Health lance un service de télémédecine au Canada, élargissant son portefeuille actuel de solutions de soins de santé
28/03/2019
La population aura accès partout et en tout temps à des soins médicaux d’excellente qualité TORONTO, 28 mars 2019 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE : TDOC), leader mondial des soins de santé virtuels, annonce [...]
Aeglea BioTherapeutics to Participate in Upcoming Investor Conferences
28/03/2019
AUSTIN, Texas, March 28, 2019 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare [...]
Nemaura CEO Provides Update to Shareholders
28/03/2019
Announces SugarBEAT® Awaiting CE Mark Approval; On Track for FDA submission in Q2 2019 Loughborough, England, March 28, 2019 (GLOBE NEWSWIRE) -- Loughborough, England – March 28, 2019 – Nemaura Medical, Inc. (NASDAQ: [...]
Genprex (GNPX) Featured in NetworkNewsWire Publication Discussing Innovative Cancer Treatments
28/03/2019
NEW YORK, March 28, 2019 (GLOBE NEWSWIRE) -- via NetworkWire — Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing [...]
ChemoCentryx Appoints Rita Jain, M.D. to Board of Directors
28/03/2019
MOUNTAIN VIEW, Calif., March 28, 2019 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq:CCXI), announced today that, effective March 27, 2019, Rita Jain, M.D., Senior Vice President and Chief Medical Officer of Akebia [...]
Canntab Therapeutics Announces Engagement of Relations Publiques Paradox Inc. for Investor Relations Services
28/03/2019
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S. TORONTO, March 28, 2019 (GLOBE NEWSWIRE) -- Canntab Therapeutics Limited (CSE: PILL) (the “ Company ” or “ Canntab ”) is pleased to [...]
Assure Holdings Selects New Billing and Collections Vendor
28/03/2019
DENVER, March 28, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, has executed an agreement with a new [...]
Fluidigm Introduces the First Complete Sample-to-Answer Solution for Deep Immune Profiling by Mass Cytometry
28/03/2019
The new standard in immune profiling for advancing translational and clinical research of immune-mediated diseases SOUTH SAN FRANCISCO, Calif., March 28, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an [...]
Innovation Pharmaceuticals European Subsidiary, IPIX Pharma Ltd., Granted Meeting with European Medicines Agency (EMA) to Discuss International Phase 3 Brilacidin Oral Mucositis Program
28/03/2019
BEVERLY, Mass., March 28, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage pharmaceutical company, announced today that the European Medicines Agency (EMA) has granted a [...]
Sarepta Therapeutics Announces Positive Expression Results from the Casimersen (SRP-4045) Arm of the ESSENCE Study
28/03/2019
-- Interim analysis found statistically significant increase in dystrophin production as measured by western blot in casimersen-treated participants compared to baseline and placebo -- -- Based on positive results, [...]
iCAD Appoints Stacey Stevens as President
28/03/2019
Appointment establishes executive infrastructure to enhance strategic and operational momentum and capitalize on significant growth opportunities Announcement follows pivotal FDA clearance and successful U.S. commercial [...]
Horizon Eye Specialists & LASIK Center Now Offers Most Advanced Custom LASIK, Guided by the iDESIGN® Advanced WaveScan Studio
28/03/2019
The practice’s use of this cutting-edge technology will result in extremely precise and personalized laser vision correction for eligible patients SCOTTSDALE, Ariz., March 28, 2019 (GLOBE NEWSWIRE) -- Horizon Eye [...]
Geron Appoints Two New Independent Board Members
28/03/2019
MENLO PARK, Calif., March 28, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced the appointments of Dawn C. Bir and Elizabeth G. O’Farrell as independent members of its Board of Directors. In [...]
BioCorRx’s Subsidiary, BioCorRx Pharmaceuticals, to Exhibit at ASAM 50th Annual Conference in Orlando, Florida
28/03/2019
ANAHEIM, CA, March 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company) , a developer and provider of advanced solutions in the treatment of substance abuse disorders, today [...]
Paratek Pharmaceuticals to Present at the 2019 H.C Wainwright Global Life Sciences Conference
28/03/2019
BOSTON, March 28, 2019 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today [...]

Pages